This book examines the role of human microbiome in human health and
diseases. The initial chapters present tools for genetic
manipulation of gut microbiota and the therapeutic applications of
engineered microbiota. They discuss the interaction between human
microbiota and host in defining the prominent role of microbes in
the development and progression of major human diseases. The book
also summarizes the current applications and trends for the
development, production and analytical characterization of
recombinant therapeutic proteins in microbial systems. It also
reviews the role of microbes in the production of vaccines and
antibiotics. Further, the book presents bacterial products,
including proteins, enzymes, immunotoxins and secondary
metabolites, that target cancer cells and cause tumour regression.
The chapters also discuss the critical role of gut microbiota
dysbiosis in the pathogenesis of autoimmune disease and in
bowel-related diseases. Towards the end, the book explores the role
of intestinal microbiota in metabolic health and the pathogenesis
of common metabolic disorders. It presents state-of-the-art
insights into important aspects of United Nations—Sustainable
Developmental Goal 3.
General
Imprint: |
Springer Verlag, Singapore
|
Country of origin: |
Singapore |
Release date: |
December 2023 |
First published: |
2024 |
Editors: |
R.C. Sobti
• Ramesh Chander Kuhad
• Rup Lal
• Parveen Rishi
|
Dimensions: |
235 x 155mm (L x W) |
Edition: |
1st ed. 2024 |
ISBN-13: |
978-981-9931-25-5 |
Categories: |
Books
|
LSN: |
981-9931-25-8 |
Barcode: |
9789819931255 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!